Evidence map›Paper›PMID 42022371›Full record

ArticleClinical and experimental hepatology2025

Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings.

Ivana Hockicková, Ján Hockicko, Peter Jarčuška, Sylvia Dražilová, František Lami, Patrícia D Lenártová, Pavol Mrážik, Adrián Gábor, Pavol Kristian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ivana HockickováDepartment of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
Ján HockickoDepartment of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
Peter Jarčuška2 Department of Internal Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
Sylvia Dražilová2 Department of Internal Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
František LamiDepartment of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
Patrícia D LenártováDepartment of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.
Pavol MrážikCorrectional Facility, Košice-Šaca, Slovakia.
Adrián GáborRemand Prison and Correctional Facility, Košice, Slovakia.
Pavol KristianDepartment of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim of the study: To evaluate the real-life experience of microelimination of chronic hepatitis C in Slovak prisons. We assessed the impact of removing treatment restrictions on the number of treated patients and the time from diagnosis to treatment initiation. Material and methods: A retrospective analysis was conducted on 205 incarcerated patients diagnosed with chronic hepatitis C between 2018 and 2024 in five prisons in Eastern Slovakia. We compared patient data before and after the removal of treatment indication restrictions. Results: Of the total of 205 patients, 94.1% ( Conclusions: The removal of treatment restrictions significantly improved access to therapy for incarcerated patients with HCV. Prisons provide a controlled setting for microelimination efforts, and expanding treatment in this population could contribute to broader national HCV elimination goals.

Indexed as

chronic hepatitis Cprisonsreal-life experiencetreatmenttreatment barriers

Identifiers

PMID42022371
PMCPMC13097283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.